H. Matsumoto et al. / Bioorg. Med. Chem. 9 (2001) 417±430
429
HRMS (FAB): m/z 504.2538 for [M+H]+ (calcd
504.2532 for C26H38N3O5S).
Terashima, K.; Kato, R.; Nojima, S.; Misawa, S.; Ueno, T.;
Imai, J.; Emonoto, H.; Tanaka, S.; Sakikawa, H.; Shintani,
M. Hayashi, H.; Kiso, Y. Chem. Pharm. Bull. 2000, 48, 1310.
6. Kiso, Y. Biopolymers 1996, 40, 235.
7. (a) Baldwin, E. T.; Bhat, T. N.; Gulnik, S.; Liu, B.; Topol,
I. A.; Kiso, Y.; Mimoto, T.; Mitsuya, H.; Erickson, J. W.
Structure 1995, 3, 581. (b) Wang, Y. X.; Freedberg, D. I.;
Yamazaki, T.; Wing®eld, P. T.; Stahl, S. J.; Kaufman, J. D.;
Kiso, Y.; Torchia, D. A. Biochemistry 1996, 35, 9945. (c) Wang,
Y. X.; Freedberg, D. I.; Wing®eld, R. T.; Stahl, S. J.; Kaufman,
J. D.; Kiso, Y.; Bhat, T. N.; Erickson, J. W.; Torchia, D. A. J.
Am. Chem. Soc. 1996, 118, 12287. (d) Ohno, Y.; Kiso, Y.;
Kobayashi, Y. Bioorg. Med. Chem. 1996, 4, 1565.
Acknowledgements
This research was supported in part by the Frontier
Research Program of the Ministry of Education, Science
and Culture of Japan, and grants from the Ministry of
Education, Science and Culture of Japan and Japan
Health Science Foundation. We thank Mr. M. Yamaguchi
(Takeda Chemical Industries, Ltd.) for the stability study,
Professor K. Sano and Dr. T. Goto (Osaka Medical Col-
lege) for helpful suggestions, and Drs. C. V. Ramesh and S.
N. Rajesh for their help in preparing the manuscript.
8. Kiso, Y.; Matsumoto, H.; Mizumoto, S.; Kimura, T.;
Fujiwara, Y.; Akaji, K. Biopolymers 1999, 51, 59.
9. (a) Kiso, Y.; Yamaguchi, S.; Matsumoto, H.; Mimoto, T.;
Kato, R.; Nojima, S.; Takaku, H.; Fukazawa, T.; Kimura, T.;
Akaji, K. Arch. Pharm. Pharm. Med. Chem. 1998, 331, 87. (b)
Mitoguchi, T.; Nakata, S.; Enomoto, H.; Kimura, T.; Akaji,
K.; Hattori, N.; Kato, R.; Mimoto, T.; Kiso, Y. In Peptide
Chemistry 1995; Nishi, N., Ed.; Protein Res. Found.: Osaka,
1996; pp 373±376.
References and Notes
1. (a) Kohl, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.;
Heimbach, J. C.; Dixon, R. A. F.; Scolnick, E. M.; Sigal, I. S.
Proc. Natl. Acad. Sci. USA 1988, 85, 4686. (b) Norbeck, D.
W.; Kempf, D. J. Annu. Rep. Med. Chem. 1991, 26, 141. (c)
Hu, J. R. J. Med. Chem. 1991, 34, 2305. (d) Martin, J. A.
Antiviral Res. 1992, 17, 265. (e) Schinazi, R. F. Perspect. Drug
Discovery Des. 1993, 1, 151. (f) Thaisrivaongs, S. Annu. Rep.
Med. Chem. 1994, 29, 133. (g) Kempf, D. J. Perspect. Drug
Discovery Des. 1994, 2, 427. (h) Darke, P. L.; Hu, J. R. Adv.
Pharmacol. 1995, 25, 399. (i) De Clercq, E. J. Med. Chem.
1995, 38, 2491. (j) West, M. L.; Fairlie, D. P. Trends Pharma-
col. Sci. 1995, 16, 67. (k) Helm, K. Biol. Chem. 1996, 377, 765.
(l) Kempf, D. J.; Sharm, H. L. Curr. Pharm. Des. 1996, 2, 225.
2. (a) Pollard, R. B. Pharmacotherapy 1994, 14, 21S. (b) Ho,
D. D.; Neumann, A. U.; Perelson, A. S.; Chen, W.; Leonard,
J. M.; Markowitz, M. Nature 1995, 373, 123. (c) Vacca, J. P.;
Condra, J. H. Drug Discovery Today 1997, 2, 261. (d) De
Clercq, E. Clin. Microbiol. Rev. 1997, 10, 674. (e) Molla, A.;
Granneman, G. R.; Sun, E.; Kempf, D. J. Antiviral Res. 1998,
39, 1.
3. (a) Craig, J. C.; Whittaker, L.; Duncan, I. B.; Roberts, N.
Antiviral Chem. Chemother. 1994, 5, 380. (b) Molla, A.;
Japour, A. Curr. Opin. Infect. Dis. 1997, 10, 491. (c) Gulick,
R.; Mellors, J.; Havlir, D.; Eron, J.; Gonzalez, C.; McMahon,
D.; Richman, D.; Valentine, F.; Jonas, L.; Meibohm, A.;
Emini, E.; Chodakewitz, J. New Engl. J. Med. 1997, 337, 734.
(d) Mathez, D.; Bagnarelli, P.; Gorin, I.; Katalama, C.; Pia-
loux, G.; Saimot, G.; Tubiana, P.; De Truchis, P.; Chauvin, J.-
P.; Mills, R.; Rode, R.; Clementi, M.; Leibowitch, J. Antiviral
Ther. 1997, 2, 175. (e) Autran, B.; Carcelain, G.; Li, T. S.;
Blanc, C.; Mathez, D.; Tubiana, R.; Katalaba, C.; Debre, P.;
Leibowitch, J. Science 1998, 277, 112. (f) Vandamme, A. M.;
Van Vaerenbergh, K.; De Clercq, E. Antiviral Chem. Chemo-
ther. 1998, 9, 187.
10. Mimoto, T.; Kato, R.; Takaku, H.; Nojima, S.; Tera-
shima, K.; Misawa, S.; Fukazawa, T.; Ueno, T.; Sato, H.;
Shintani, M.; Kiso, Y.; Hayashi, H. J. Med. Chem. 1999, 42,
1789.
11. Bundgaard, H. In Bioreversible Carriers in Drug Design:
Theory and Application; Roche, E. B., Ed.; Pergamon Press:
New York, 1987; pp 13±94.
12. (a) Iley, J.; Moreira, R.; Calheiros, T.; Mendes, E. Pharm.
Res. 1997, 14, 1634. (b) Moreira, R.; Mendes, E.; Calheiros,
T.; Bacelo, M. J.; Iley, J. Tetrahedron Lett. 1994, 35, 7107.
13. Daehne, W. V.; Frederiksen, E.; Gundersen, E.; Lund, F.;
March, P.; Petersen, H. J.; Roholt, K.; Tybring, L.; Godt-
fredsen, W. O. J. Med. Chem. 1970, 13, 607.
14. Ulm, E. H.; Hichens, M.; Gomez, H. J.; Till, A. E.; Hamd,
E.; Vassil, T. C.; Biollaz, J.; Brunner, H. R.; Schelling, J. L.
Br. J. Pharmacol. 1982, 14, 357.
15. Sinkula, A. A. In Medicinal Chemistry; Mathieeu, J., Ed.;
Elsevier: Amsterdam, 1977; pp 125±696.
16. Wermuth, C. G.; Gaignault, J.-C.; Marchandeau, C. In
The Practice of Medicinal Chemistry, Wermuth, C. G., Ed.;
Academic Press: London, 1996; p 671.
17. Mitsuya, H.; Weinhold, K.; Furman, P. A.; Clair, M. H.
S.; Lehman, S. N.; Gallo, R. C.; Bolognesi, D.; Barry, D. W.;
Broder, S. Proc. Natl. Acad. Sci. USA 1985, 82, 7096.
18. (a) Huang, Q.-Q.; Yao, S. Y. M.; Ritzel, M. W. L.;
Paterson, A. R. P.; Cass, C. E.; Young, J. D. J. Biol. Chem.
1994, 269, 17757. (b) Chan, T. C. K.; Shaer, L.; Redmond,
R.; Pennington, K. L. Biochem. Pharmacol. 1993, 46, 273. (c)
Domin, B. A.; Mahony, W. B.; Zimmerman, T. P. Biochem.
Pharmacol. 1993, 46, 725.
19. For reviews of nucleoside transporters and receptors, see:
(a) Cass, C. E.; Young, J. D.; Baldwin, S. A. Biochem. Cell
Biol. 1998, 76, 761. (b) Ralevic, V.; Burnstock, G. Pharmacol.
Rev. 1998, 50, 413.
4. (a) Mimoto, T.; Imai, J.; Tanaka, S.; Hattori, N.; Takaha-
shi, O.; Kisanuki, S.; Nagano, Y.; Shintani, M.; Hayashi, H.;
Sakikawa, H.; Akaji, K.; Kiso, Y. Chem. Pharm. Bull. 1991,
39, 2465. (b) Mimoto, T.; Imai, J.; Tanaka, S.; Hattori, N.;
Kisanuki, S.; Akaji, K.; Kiso, Y. Chem. Pharm. Bull. 1991, 39,
3088.
5. (a) Mimoto, T.; Imai, J.; Kisanuki, S.; Enomoto, H.; Hat-
tori, N.; Akaji, K.; Kiso, Y. Chem. Pharm. Bull. 1992, 40,
2251. (b) Kageyama, S.; Mimoto, T.; Murakawa, Y.; Nomizu,
M.; Ford, H. Jr.; Shirasaka, T.; Gulnik, S.; Erickson, J.;
Takada, K.; Hayashi, H.; Broder, S.; Kiso, Y.; Mitsuya, H.
Antimicrob. Agents Chemother. 1993, 37, 810. (c) Mimoto,
T.; Hattori, N.; Takaku, H.; Kisanuki, S.; Fukazawa, T.;
20. Kimura, T.; Matsumoto, H.; Matsuda, T.; Hamawaki, T.;
Akaji, K.; Kiso, Y. Bioorg. Med. Chem. Lett. 1999, 9, 803.
21. Kiso, Y.; Matsumoto, H.; Yamaguchi, S.; Kimura, T.
Letters in Peptide Science 1999, 6, 275.
22. (a) Tadayoni, B. M.; Friden, P. M.; Walus, L. R.; Musso,
G. F. Bioconjugate Chem. 1993, 4, 139. (b) Tamamura, H.;
Ishihara, T.; Oyake, H.; Imai, M.; Otaka, A.; Ibuka, T.; Ara-
kaki, R.; Nakashima, H.; Murakami, T.; Waki, M.; Matsu-
moto, A.; Yamamoto, N.; Fujii, N. J. Chem. Soc., Perkin
Trans. 1 1998, 495.
23. Bilello, J. A.; Bilello, P. A.; Stellrecht, K.; Leonard, J.;
Norbeck, D. W.; Kempf, D. J.; Robins, T.; Drusano, G. L.
Antimicrob. Agents Chemother. 1996, 40, 1491.